Merck KGaA restructured its pharmaceuticals business in Germany
Today in Darmstadt, the Managing Director of the new company, Rosemarie Schiemer, stated that Merck Pharma GmbH, as a independent company, would gain more room for entrepreneurial maneuver: "Despite this change, Merck Pharma GmbH is and remains a part of Merck. However, this greater independence is necessary to respond flexibly to the challenges of the constantly changing healthcare market."
With around 400 employees, the company markets approximately 60 ethical drugs, in particular for treatment of cancer, cardiovascular diseases, thyroid diseases, and diabetes. Merck Pharma GmbH is one of the leading companies in Germany for systemic corticoids that are used, for example, in severe inflammation of joints or vessels.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.